 Claudia Staab-Weijnitz
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchi | 5 | 2025 | 270 | 2.520 |
Why?
| | Idiopathic Pulmonary Fibrosis | 10 | 2025 | 659 | 2.390 |
Why?
| | Epithelial Cells | 9 | 2025 | 1110 | 2.380 |
Why?
| | Tacrolimus Binding Proteins | 5 | 2022 | 27 | 1.950 |
Why?
| | Respiratory Mucosa | 4 | 2025 | 330 | 1.810 |
Why?
| | Pulmonary Fibrosis | 6 | 2024 | 400 | 1.510 |
Why?
| | Lung | 11 | 2025 | 4134 | 0.990 |
Why?
| | Extracellular Matrix Proteins | 3 | 2023 | 157 | 0.940 |
Why?
| | Fibroblasts | 8 | 2023 | 1020 | 0.930 |
Why?
| | Cell Differentiation | 5 | 2025 | 2003 | 0.880 |
Why?
| | Cell Nucleus | 2 | 2025 | 609 | 0.860 |
Why?
| | Regeneration | 1 | 2025 | 198 | 0.820 |
Why?
| | Cholesterol | 1 | 2025 | 405 | 0.810 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2025 | 528 | 0.700 |
Why?
| | Lung Diseases | 2 | 2025 | 794 | 0.630 |
Why?
| | Extracellular Matrix | 4 | 2025 | 555 | 0.570 |
Why?
| | Collagen Type VI | 1 | 2018 | 5 | 0.570 |
Why?
| | Fibrillar Collagens | 1 | 2017 | 14 | 0.540 |
Why?
| | Glutathione Peroxidase | 1 | 2016 | 43 | 0.500 |
Why?
| | Models, Biological | 2 | 2021 | 1828 | 0.500 |
Why?
| | Smoking | 2 | 2021 | 1601 | 0.490 |
Why?
| | Drug Repositioning | 1 | 2016 | 39 | 0.490 |
Why?
| | Pyridones | 1 | 2017 | 176 | 0.470 |
Why?
| | Cell Movement | 3 | 2018 | 990 | 0.450 |
Why?
| | Up-Regulation | 5 | 2024 | 859 | 0.430 |
Why?
| | Bronchopneumonia | 1 | 2014 | 6 | 0.430 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 368 | 0.430 |
Why?
| | Glutaredoxins | 1 | 2014 | 13 | 0.430 |
Why?
| | fas Receptor | 1 | 2014 | 97 | 0.410 |
Why?
| | Indoles | 1 | 2017 | 429 | 0.410 |
Why?
| | Cells, Cultured | 5 | 2025 | 4208 | 0.410 |
Why?
| | Lung Diseases, Interstitial | 2 | 2017 | 655 | 0.400 |
Why?
| | Fibrosis | 5 | 2023 | 541 | 0.390 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 230 | 0.360 |
Why?
| | Collagen | 3 | 2023 | 459 | 0.360 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 358 | 0.350 |
Why?
| | Transforming Growth Factor beta1 | 3 | 2023 | 171 | 0.340 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 3 | 2017 | 9 | 0.320 |
Why?
| | Cigarette Smoking | 2 | 2023 | 103 | 0.320 |
Why?
| | Humans | 33 | 2025 | 141187 | 0.310 |
Why?
| | Protein Transport | 3 | 2025 | 448 | 0.270 |
Why?
| | Basement Membrane | 1 | 2025 | 33 | 0.240 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2025 | 14 | 0.240 |
Why?
| | Collagen Type IV | 1 | 2025 | 28 | 0.230 |
Why?
| | Naphthalenes | 1 | 2025 | 59 | 0.230 |
Why?
| | Airway Remodeling | 1 | 2025 | 70 | 0.230 |
Why?
| | Receptors, Purinergic P2X4 | 1 | 2024 | 6 | 0.220 |
Why?
| | Receptors, Purinergic P2X7 | 1 | 2024 | 12 | 0.220 |
Why?
| | Bleomycin | 2 | 2016 | 248 | 0.220 |
Why?
| | Down-Regulation | 2 | 2017 | 641 | 0.220 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2025 | 429 | 0.220 |
Why?
| | Myofibroblasts | 2 | 2023 | 128 | 0.210 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.210 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 1049 | 0.200 |
Why?
| | Animals | 12 | 2025 | 37657 | 0.200 |
Why?
| | Coronavirus 229E, Human | 1 | 2022 | 7 | 0.190 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2024 | 556 | 0.190 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4404 | 0.190 |
Why?
| | Peptidylprolyl Isomerase | 1 | 2022 | 9 | 0.190 |
Why?
| | MicroRNAs | 2 | 2023 | 689 | 0.190 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 11 | 0.180 |
Why?
| | Coronavirus | 1 | 2022 | 47 | 0.180 |
Why?
| | Mice | 8 | 2025 | 18048 | 0.180 |
Why?
| | Plasma Cells | 1 | 2022 | 74 | 0.180 |
Why?
| | TRPM Cation Channels | 1 | 2022 | 75 | 0.180 |
Why?
| | Oxidative Stress | 2 | 2019 | 1330 | 0.170 |
Why?
| | Radiation Pneumonitis | 1 | 2020 | 31 | 0.170 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 150 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5887 | 0.160 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2024 | 348 | 0.160 |
Why?
| | Collagen Type I | 2 | 2017 | 139 | 0.160 |
Why?
| | Cathepsins | 1 | 2019 | 23 | 0.160 |
Why?
| | Vitamin K 3 | 2 | 2016 | 3 | 0.150 |
Why?
| | Mice, Knockout | 2 | 2024 | 3068 | 0.150 |
Why?
| | Autophagy | 1 | 2021 | 287 | 0.150 |
Why?
| | Radiation Injuries | 1 | 2020 | 149 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2024 | 2180 | 0.150 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2018 | 12 | 0.150 |
Why?
| | Smokers | 1 | 2019 | 144 | 0.150 |
Why?
| | S100 Calcium-Binding Protein A4 | 1 | 2018 | 4 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1478 | 0.140 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 117 | 0.140 |
Why?
| | Immunoglobulin G | 1 | 2022 | 900 | 0.140 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2017 | 6 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2024 | 1154 | 0.130 |
Why?
| | Pneumonia | 1 | 2023 | 656 | 0.130 |
Why?
| | Epithelium | 1 | 2018 | 316 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2022 | 371 | 0.130 |
Why?
| | Transcription Factors | 1 | 2025 | 1703 | 0.130 |
Why?
| | Macrophage Activation | 1 | 2018 | 200 | 0.130 |
Why?
| | Plasma | 1 | 2017 | 220 | 0.120 |
Why?
| | Skin Diseases | 1 | 2017 | 147 | 0.120 |
Why?
| | Caloric Restriction | 1 | 2017 | 124 | 0.120 |
Why?
| | Demography | 1 | 2016 | 296 | 0.120 |
Why?
| | Pulmonary Alveoli | 1 | 2018 | 410 | 0.120 |
Why?
| | Macrophages, Alveolar | 1 | 2018 | 396 | 0.110 |
Why?
| | Kidney Cortex | 1 | 2014 | 26 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2599 | 0.110 |
Why?
| | Kidney Medulla | 1 | 2014 | 31 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1892 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 464 | 0.110 |
Why?
| | Cytokines | 2 | 2023 | 2098 | 0.110 |
Why?
| | Signal Transduction | 3 | 2025 | 5144 | 0.100 |
Why?
| | Smoke | 1 | 2015 | 148 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2016 | 650 | 0.100 |
Why?
| | Tobacco Products | 1 | 2015 | 129 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3348 | 0.100 |
Why?
| | S-Nitrosoglutathione | 1 | 2013 | 8 | 0.100 |
Why?
| | Proteome | 1 | 2017 | 483 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 368 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 595 | 0.100 |
Why?
| | Alcohol Oxidoreductases | 1 | 2013 | 61 | 0.090 |
Why?
| | Reperfusion Injury | 1 | 2014 | 292 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2019 | 3588 | 0.090 |
Why?
| | Momordica charantia | 1 | 2011 | 15 | 0.090 |
Why?
| | Cysteine | 1 | 2013 | 205 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2016 | 1250 | 0.090 |
Why?
| | Alveolar Epithelial Cells | 2 | 2025 | 115 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1487 | 0.080 |
Why?
| | Male | 8 | 2025 | 69783 | 0.080 |
Why?
| | Plant Extracts | 1 | 2011 | 209 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 819 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2023 | 747 | 0.060 |
Why?
| | Female | 7 | 2025 | 75515 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2023 | 2828 | 0.060 |
Why?
| | Aged | 4 | 2019 | 24574 | 0.060 |
Why?
| | Biomarkers | 3 | 2025 | 4174 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2166 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2746 | 0.050 |
Why?
| | TRPA1 Cation Channel | 1 | 2023 | 5 | 0.050 |
Why?
| | Luciferases, Renilla | 1 | 2022 | 4 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2560 | 0.050 |
Why?
| | Immunity | 1 | 2023 | 140 | 0.050 |
Why?
| | Fibrinolysin | 1 | 2022 | 21 | 0.050 |
Why?
| | Cyclophilins | 1 | 2022 | 40 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2017 | 593 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 89 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2011 | 1365 | 0.050 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2023 | 209 | 0.050 |
Why?
| | Fibronectins | 1 | 2022 | 135 | 0.050 |
Why?
| | Cyclosporine | 1 | 2022 | 265 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2025 | 624 | 0.040 |
Why?
| | Epitopes | 1 | 2023 | 477 | 0.040 |
Why?
| | Tacrolimus | 1 | 2022 | 198 | 0.040 |
Why?
| | Middle Aged | 3 | 2019 | 34434 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 330 | 0.040 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 178 | 0.040 |
Why?
| | Proteomics | 2 | 2017 | 1134 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 281 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 737 | 0.040 |
Why?
| | Virus Replication | 1 | 2021 | 532 | 0.040 |
Why?
| | Niclosamide | 1 | 2018 | 2 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 372 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 57 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 74 | 0.040 |
Why?
| | Oxidation-Reduction | 2 | 2013 | 1086 | 0.040 |
Why?
| | Biocatalysis | 1 | 2018 | 69 | 0.040 |
Why?
| | Protein Binding | 1 | 2024 | 2239 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3292 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2022 | 854 | 0.030 |
Why?
| | Gene Silencing | 1 | 2018 | 196 | 0.030 |
Why?
| | Tissue Survival | 1 | 2017 | 18 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 918 | 0.030 |
Why?
| | Prognosis | 1 | 2025 | 4073 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 213 | 0.030 |
Why?
| | Intra-Abdominal Fat | 1 | 2017 | 90 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2018 | 352 | 0.030 |
Why?
| | RNA | 1 | 2022 | 930 | 0.030 |
Why?
| | Adult | 2 | 2017 | 39177 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1561 | 0.030 |
Why?
| | Keratin-14 | 1 | 2015 | 15 | 0.030 |
Why?
| | Uteroglobin | 1 | 2015 | 24 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 396 | 0.030 |
Why?
| | Synchrotrons | 1 | 2014 | 13 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2015 | 70 | 0.030 |
Why?
| | Swine | 1 | 2017 | 806 | 0.030 |
Why?
| | Acetylation | 1 | 2015 | 245 | 0.030 |
Why?
| | Eating | 1 | 2017 | 392 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 199 | 0.030 |
Why?
| | Wound Healing | 1 | 2017 | 348 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 519 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1737 | 0.030 |
Why?
| | Tubulin | 1 | 2015 | 146 | 0.030 |
Why?
| | Metabolome | 1 | 2017 | 366 | 0.030 |
Why?
| | Hexanones | 1 | 2013 | 2 | 0.020 |
Why?
| | Daunorubicin | 1 | 2013 | 25 | 0.020 |
Why?
| | Naphthoquinones | 1 | 2013 | 18 | 0.020 |
Why?
| | Mice, Nude | 1 | 2014 | 691 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2012 | 71 | 0.020 |
Why?
| | Luciferases | 1 | 2012 | 150 | 0.020 |
Why?
| | Cortisone | 1 | 2011 | 16 | 0.020 |
Why?
| | Microsomes | 1 | 2011 | 33 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 149 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 274 | 0.020 |
Why?
| | Enzyme Assays | 1 | 2011 | 25 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1274 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 274 | 0.020 |
Why?
| | Hepatocytes | 1 | 2012 | 211 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2885 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1764 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2504 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 772 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1093 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5629 | 0.020 |
Why?
| | Kinetics | 1 | 2013 | 1652 | 0.020 |
Why?
| | Apoptosis | 1 | 2018 | 2574 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1316 | 0.020 |
Why?
| | Pyridines | 1 | 2013 | 510 | 0.020 |
Why?
| | Base Sequence | 1 | 2012 | 2180 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2158 | 0.020 |
Why?
| | Liver | 1 | 2017 | 1819 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2929 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1752 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 7856 | 0.010 |
Why?
| | Placenta | 1 | 2011 | 761 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3469 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 7070 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2526 | 0.010 |
Why?
|
|
Staab-Weijnitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|